World Health Organisation has listed two additional mpox in vitro diagnostics under its Emergency Use Listing procedure to enhance quality-assured testing options. The organisation stated this in a statement on Wednesday. The organisation stated that “WHO’s EUL is based on the review of quality, safety and performance data in compliance with international standards, while addressing Read More
Related Articles
Don't miss out on breaking stories and in-depth articles.